Member Info for Joshholdforgold

First off what a great response from the market following a stop loss raid this morning!

I went through the Twitter profiles of Mark, Kevin, Suzy and Valirx looking for Pharma profiles which they followed (3 out 4 actually was my criteria). I discounted any biotech pharma with Mcap less than £100m as not being able to afford to take the drug through phase 2 and 3 clinical trials.

This left a surprisingly short list.

I then looked at the last 6 months tweeting and linkedIn history for posts which had been liked or retweeted either way.

AZ was the winner with Merck in second place.

For me the key supporting piece of info comes from a lady called Susan Galbraith. She has liked Suzy or Valirx's posts and visa versa. She is the Executive VP of Oncolgy R&D for AZ. This is the only senior member of a major pharma to have interacted with Valirx or Suzy on LinkedIn or Twitter.

She is one hell of a heavyweight taking a professional interest in Valirx and Suzy.

If I am correct, the prestige of a partnership with AZ would quite simply revolutionise the fortunes of little old Valirx. Combine that with £5m upfront and this will multibag from here.

https://twitter.com/Joshblakemore8/status/1453000668248219651?s=20

I missed the morning top up opportunity. Really annoyed! I had some cash ready as well!

Punit even.

Pinot yes that’s it.

Haha. What was the guys user name again?

Ice! I think we might have a very similar portfolio.

It’s going to be a good week here and in Val.

LesGo!

I topped up at 2.48 so don’t worry you’re not the only one yo have bought at that level.

Many of you may have seen my post a few months back explaining why I believe 301 is with Tadeka.

I have a theory, a really good one, about 201.

Look at who Suzy follows and who follows Suzy on Twitter and see if you can connect any dots.

I’m in the process of writing full justification for my theory but I’d be interested to see if anyone else comes to the same conclusion. Part 2 tomorrow.

Spoiler: it’s good.

Sng gapped up the other day. It’s seen another 25% plus since the gap. No sign of a retrace.

100s more examples I’m sure.

We will hit 65p.

Write it down, put it in your bedside draw and tattoo it on your forehead.

Then come back and admit you were wrong.

I’ve been spot on with my previous 3 targets of 41, 49 and 55p.

18 months since buying in I’m still around. Looking forward to that party!

The volume on the rises is actually increasing, implying the trend is strengthening rather than topping out.

For anyone who holds value in such things, here is my chart forecast:

https://twitter.com/Joshblakemore8/status/1451494660669575201?s=20

Have a look back at my forecasts over the last 2 months. I've done pretty well if I do say so myself.

ATB

Josh

Kelvin - operation sloth speed haha

But seriously this will enable eua for a different treatment of disease which will come after hospital use. The US government has essentially committed to funding another $100m of synairgen's development. FKN Fantastic!

Al- apologies not awake yet! I thought the actual weasel A1 had put this up because he’d got scared.

Bravo sir!

Lying bedwetter.

Please get back in your box and stay there.

My understanding is that the contract works had a time limit of 9 months (ending 15th Nov) so PYCs input may be complete already.
It could also be that an agreement is there in principal subject to PYC confirmation of xyz.

Take a look at the chart.

https://twitter.com/joshblakemore8/status/1449730290860048393?s=21

52p is the top of our current rising channel.

There must be a very strong chance that Suzy’s Sunday Roast interview was so good that it pushes us above the 52p mark and on to re-test last years high at 73p.

I’m buzzing with excitement. Not a lot of my day job is getting done today!

ATB

Josh

Badsterman - have you listened yet? Those quotes were spot on and Porky was mentioned by name.

Perhaps that will buy a bit of credibility now!